Top

Clinical Rheumatology

Published in:

01-02-2021 | Coronavirus | Letter to the Editor

Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic

Authors: Steffen Springer, Artur Strzelecki, Michael Zieger

Published in: Clinical Rheumatology | Issue 2/2021

Excerpt

Dear Editor, …

Dey M, Zhao SS (2020) COVID-19, and Kawasaki disease: an analysis using Google Trends. Clin Rheumatol 39:2483–2484. https://doi.org/10.1007/s10067-020-05231-zCrossRefPubMed

Freeman AF, Shulman ST (2006) Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician 74(7):1141–1148PubMed

Onouchi Y (2018) The genetics of Kawasaki disease. Int J Rheum Dis 21:26–30. https://doi.org/10.1111/1756-185X.13218CrossRefPubMed

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB et al (2020) COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 10:537–540. https://doi.org/10.1542/hpeds.2020-0123CrossRefPubMed

Waltuch T, Gill P, Zinns LE et al (2020) Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 38:2246.e3–2246.e6. https://doi.org/10.1016/j.ajem.2020.05.058CrossRef

Riphagen S, Gomez X, Gonzalez-Martinez C et al (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395:1607–1608. https://doi.org/10.1016/S0140-6736(20)31094-1CrossRefPubMedPubMedCentral

Lie Morand A, Urbina D, Fabre A (2020) COVID-19 and Kawasaki like disease: the known-known, the unknown-known and the unknown-unknown. https://doi.org/10.20944/PREPRINTS202005.0160.V1

DeBiasi RL, Song X, Delaney M et al (2020) Severe coronavirus disease-2019 in children and young adults in the Washington, DC, Metropolitan Region. J Pediatr 223:199–203.e1. https://doi.org/10.1016/j.jpeds.2020.05.007

Mahase E (2020) Covid-19: concerns grow over inflammatory syndrome emerging in children. BMJ m1710. https://doi.org/10.1136/bmj.m1710

10.

Verdoni L, Mazza A, Gervasoni A et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395:1771–1778. https://doi.org/10.1016/S0140-6736(20)31103-XCrossRefPubMedPubMedCentral

Title: Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic
Authors: Steffen Springer
Artur Strzelecki
Michael Zieger
Publication date: 01-02-2021
Publisher: Springer International Publishing
Keywords: Coronavirus
COVID-19
Kawasaki Disease
Kawasaki Disease
Kawasaki Disease
Published in: Clinical Rheumatology / Issue 2/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05535-0

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2021

Metabolic syndrome, hypertension, and hyperglycemia were positively associated with knee osteoarthritis, while dyslipidemia showed no association with knee osteoarthritis

Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis

Lower risk of primary Sjogren’s syndrome in patients with dengue virus infection: a nationwide cohort study in Taiwan

Can therapeutic response to IL-1 blockade confirm the diagnosis of Schnitzler syndrome?

The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies

Pulmonary artery involvement in Takayasu arteritis: a retrospective study in Chinese population

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage